网友提问：
长春高新(000661)
Alvogen’s sister company Alvotech has entered into an exciting joint venture with China-based biopharmaceutical firm Changchun High & New Technology (CCHN).The agreement will enable us to develop, manufacture and commercialize our biosimilar portfolio in China, where a new state-of-the-art biologics drugs manufacturing facility will be built in Changchun.We’ve been looking for a route into China, the second largest and fastest growing pharma market in the world, for a long time. However, we had to make sure that the firm we partnered with was the right one.CCHN are an established company in Ch
网友回复
luotiger：
c8**99
luotiger：
888
luotiger：
*****互相提醒～女～～～～～*～
luotiger：
*么+44还
luotiger：
b不。